Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
156
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Expression of YT Domain Family Protein in Oral Squamous Cell Carcinoma and Its Correlation with the Prognosis

Rui Shi1 Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People’s Republic of China;2 School of Stomatology of Qingdao University, Qingdao, People’s Republic of ChinaView further author information
,
Shao-Ming Li1 Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People’s Republic of China;3 Key Laboratory of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of ChinaView further author information
,
Ling Gao1 Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People’s Republic of China;3 Key Laboratory of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of ChinaView further author information
,
Ke-Qian Zhi1 Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People’s Republic of China;3 Key Laboratory of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Wen-Hao Ren1 Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People’s Republic of China;3 Key Laboratory of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4167-2933View further author information
ORCID Icon
Pages 2263-2270 | Received 02 Feb 2023, Accepted 25 May 2023, Published online: 05 Jun 2023

References

  • Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma. Int J Mol Sci. 2018;19(8):2413. doi:10.3390/ijms19082413
  • Zanoni DK, Montero PH, Migliacci JC, et al. Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol. 2019;90:115–121. doi:10.1016/j.oraloncology.2019.02.001
  • Ma S, Chen C, Ji X, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121. doi:10.1186/s13045-019-0805-7
  • Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613. doi:10.1016/j.biopha.2019.108613
  • Roignant J-Y, Soller M. m6A in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genet. 2017;33(6):380–390. doi:10.1016/j.tig.2017.04.003
  • Zhou B, Liu C, Xu L, et al. N6 -methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes. Hepatology. 2021;73(1):91–103. doi:10.1002/hep.31220
  • Zhao W, Qi X, Liu L, Ma S, Liu J, Wu J. Epigenetic regulation of m6A modifications in human cancer. Mol Ther Nucleic Acids. 2020;19:405–412. doi:10.1016/j.omtn.2019.11.022
  • Worpenberg L, Paolantoni C, Longhi S, et al. Ythdf is a N6-methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila. EMBO J. 2021;40(4):e104975. doi:10.15252/embj.2020104975
  • Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 2017;27(3):315–328. doi:10.1038/cr.2017.15
  • Niu Y, Zhao X, Wu Y-S, Li -M-M, Wang X-J, Yang Y-G. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11(1):8–17. doi:10.1016/j.gpb.2012.12.002
  • Wang X, Zhao BS, Roundtree IA, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6):1388–1399. doi:10.1016/j.cell.2015.05.014
  • Kasowitz SD, Ma J, Anderson SJ, et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 2018;14(5):e1007412. doi:10.1371/journal.pgen.1007412
  • Liu S, Li G, Li Q, et al. The roles and mechanisms of YTH domain-containing proteins in cancer development and progression. Am J Cancer Res. 2020;10(4):1068–1084.
  • Liu L, Liu X, Dong Z, et al. N6-methyladenosine-related genomic targets are altered in breast cancer tissue and associated with poor survival. J Cancer. 2019;10(22):5447–5459. doi:10.7150/jca.35053
  • Zhao W, Cui Y, Liu L, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-myc stability via YTHDF1-mediated m6A modification. Mol Ther Nucleic Acids. 2020;20:1–2.
  • Zhao X, Chen Y, Mao Q, et al. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Biomark. 2018;21(4):859–868. doi:10.3233/CBM-170791
  • Jin D, Guo J, Wu Y, et al. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 2019;12(1):135. doi:10.1186/s13045-019-0830-6
  • Wang P, Wang X, Zheng L, Zhuang C. Gene signatures and prognostic values of m6A regulators in hepatocellular carcinoma. Front Genet. 2020;11:540186. doi:10.3389/fgene.2020.540186

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.